WEST PHARMACEUTICAL SERVICES, INC. Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Other Income
us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments · last filed 2026-02-17
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for the quarter ending 2023-12-31 was -$100.00K.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for the quarter ending 2023-09-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for the quarter ending 2022-12-31 was -$1.40M.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for the quarter ending 2022-09-30 was -$49.60M.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2025 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2024 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2023 was -$100.00K.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2022 was -$52.20M.
| Period end | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment 3 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment 6 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment 9 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-17 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-17 | |||
| 2023-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$100.00K derived: sum of 2 quarters · filed 2026-02-17 | -$100.00K 10-K · filed 2026-02-17 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | $0.00 10-Q · filed 2023-10-26 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-07-27 | |||
| 2022-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$51.00M derived: sum of 2 quarters · filed 2025-02-18 | -$51.60M derived: sum of 3 quarters · filed 2025-02-18 | -$52.20M 10-K · filed 2025-02-18 |
| 2022-09-30 | -$49.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$50.20M derived: sum of 2 quarters · filed 2023-10-26 | -$50.80M 10-Q · filed 2023-10-26 | |
| 2022-06-30 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | -$1.20M 10-Q · filed 2023-07-27 | ||
| 2022-03-31 | -$600.00K 10-Q · filed 2022-04-28 | |||
| 2021-12-31 | -$1.80M 10-K · filed 2024-02-20 | |||
| 2021-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | -$700.00K 10-Q · filed 2022-07-28 | ||
| 2021-03-31 | -$600.00K 10-Q · filed 2022-04-28 | |||
| 2020-12-31 | -$3.70M 10-K · filed 2023-02-21 | |||
| 2019-12-31 | -$3.50M 10-K · filed 2022-02-22 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-23 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $2.10M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 | |||
| 2012-09-30 | $0.00 10-Q · filed 2012-11-05 | $0.00 10-Q · filed 2012-11-05 | ||
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $200.00K derived: sum of 2 quarters · filed 2012-11-05 | $200.00K 10-K/A · filed 2012-03-01 | |
| 2011-09-30 | $200.00K 10-Q · filed 2012-11-05 | $200.00K 10-Q · filed 2012-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |